159 related articles for article (PubMed ID: 30071251)
1. Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight.
Mylonaki I; Allémann E; Delie F; Jordan O
J Control Release; 2018 Sep; 286():231-239. PubMed ID: 30071251
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Diprophylline dispersions.
Tamani F; Bassand C; Hamoudi MC; Danede F; Willart JF; Siepmann F; Siepmann J
Int J Pharm; 2019 Dec; 572():118819. PubMed ID: 31726196
[TBL] [Abstract][Full Text] [Related]
3. Co-Delivery of Atorvastatin Nanocrystals in PLGA based in situ Gel for Anti-Hyperlipidemic Efficacy.
Kurakula M; Ahmed TA
Curr Drug Deliv; 2016; 13(2):211-20. PubMed ID: 26549039
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Monolithic dispersions studied at lower temperatures.
Tamani F; Bassand C; Hamoudi MC; Siepmann F; Siepmann J
Int J Pharm; 2021 Mar; 596():120220. PubMed ID: 33486018
[TBL] [Abstract][Full Text] [Related]
5. Potential Roles of the Glass Transition Temperature of PLGA Microparticles in Drug Release Kinetics.
Park K; Otte A; Sharifi F; Garner J; Skidmore S; Park H; Jhon YK; Qin B; Wang Y
Mol Pharm; 2021 Jan; 18(1):18-32. PubMed ID: 33331774
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of chitosan/polyvinylpyrrolidone hydrogel scaffolds containing PLGA microparticles loaded with dexamethasone for biomedical applications.
Saeedi Garakani S; Davachi SM; Bagher Z; Heraji Esfahani A; Jenabi N; Atoufi Z; Khanmohammadi M; Abbaspourrad A; Rashedi H; Jalessi M
Int J Biol Macromol; 2020 Dec; 164():356-370. PubMed ID: 32682976
[TBL] [Abstract][Full Text] [Related]
7. The effect of PLGA molecular weight differences on risperidone release from microspheres.
Kohno M; Andhariya JV; Wan B; Bao Q; Rothstein S; Hezel M; Wang Y; Burgess DJ
Int J Pharm; 2020 May; 582():119339. PubMed ID: 32305366
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin loaded PLGA microspheres: Preparation, HAp coating, drug release and effect on osteogenic differentiation of ADMSCs.
Shokrolahi F; Khodabakhshi K; Shokrollahi P; Badiani R; Moghadam ZM
Int J Pharm; 2019 Jun; 565():95-107. PubMed ID: 31071416
[TBL] [Abstract][Full Text] [Related]
9. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
10. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Qin B; Schwendeman SP
Mol Pharm; 2020 Nov; 17(11):4141-4151. PubMed ID: 32876463
[TBL] [Abstract][Full Text] [Related]
11. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
[TBL] [Abstract][Full Text] [Related]
12. Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites.
Gu B; Sun X; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2016 Apr; 228():170-178. PubMed ID: 26965956
[TBL] [Abstract][Full Text] [Related]
13. PLGA/chitosan-heparin composite microparticles prepared with microfluidics for the construction of hMSC aggregates.
Ge M; Sheng Y; Qi S; Cao L; Zhang Y; Yang J
J Mater Chem B; 2020 Nov; 8(43):9921-9932. PubMed ID: 33034328
[TBL] [Abstract][Full Text] [Related]
14. Prolonging food shelf-life by dual actives release from multi-layered polymer particles.
Biswal AK; Saha S
Colloids Surf B Biointerfaces; 2019 Mar; 175():281-290. PubMed ID: 30551015
[TBL] [Abstract][Full Text] [Related]
15. Polymer erosion in PLGA microparticles produced by phase separation method.
Husmann M; Schenderlein S; Lück M; Lindner H; Kleinebudde P
Int J Pharm; 2002 Aug; 242(1-2):277-80. PubMed ID: 12176263
[TBL] [Abstract][Full Text] [Related]
16. The mechanism behind the biphasic pulsatile drug release from physically mixed poly(dl-lactic(-co-glycolic) acid)-based compacts.
Beugeling M; Grasmeijer N; Born PA; van der Meulen M; van der Kooij RS; Schwengle K; Baert L; Amssoms K; Frijlink HW; Hinrichs WLJ
Int J Pharm; 2018 Nov; 551(1-2):195-202. PubMed ID: 30223077
[TBL] [Abstract][Full Text] [Related]
17. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration.
Widmer MS; Gupta PK; Lu L; Meszlenyi RK; Evans GR; Brandt K; Savel T; Gurlek A; Patrick CW; Mikos AG
Biomaterials; 1998 Nov; 19(21):1945-55. PubMed ID: 9863528
[TBL] [Abstract][Full Text] [Related]
18. Tunable sustained release drug delivery system based on mononuclear aqueous core-polymer shell microcapsules.
Abulateefeh SR; Alkawareek MY; Alkilany AM
Int J Pharm; 2019 Mar; 558():291-298. PubMed ID: 30641178
[TBL] [Abstract][Full Text] [Related]
19. Polymer degradation induced drug precipitation in PLGA implants - Why less is sometimes more.
Zlomke C; Barth M; Mäder K
Eur J Pharm Biopharm; 2019 Jun; 139():142-152. PubMed ID: 30902733
[TBL] [Abstract][Full Text] [Related]
20. Micro vs. nano: PLGA particles loaded with trimethoprim for instillative treatment of urinary tract infections.
Brauner B; Schwarz P; Wirth M; Gabor F
Int J Pharm; 2020 Apr; 579():119158. PubMed ID: 32081799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
